X T L Biopharmaceuticals reported $76K in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Alaunos Therapeutics USD 124K 230K Jun/2026
Bioline Rx USD 4.63M 2.12M Jun/2026
Teva Pharmaceutical Industries USD 4.08B 430M Sep/2026
X T L Biopharmaceuticals USD 76K 295K Dec/2025